Further to one of our  recent post made here in relation to news of the non-invasive prenatal screening test under development by Sequenom inthe US, we are posting a copy of a position  statement issued by the NDSS (National Down Syndrome Society). We note that the Sequenom share price continues to rise with latest reports of a 67.7% increase ...

Reports from the internet this week bring news of a new non-invasive prenatal screening test for Down syndrome which we are sure will prove to be very controversial and will raise many questions and issues should it's recent successes lead to an eventual product launch. 

On Wednesday last (04.06.08) , Sequenom, a San-Diego based company which provides genetic-analysis ...